Phase I Trial of Combination Pegylated Liposomal Doxorubicin (Doxil), Vinorelbine, and Gemcitabine

Trial Profile

Phase I Trial of Combination Pegylated Liposomal Doxorubicin (Doxil), Vinorelbine, and Gemcitabine

Completed
Phase of Trial: Phase I

Latest Information Update: 03 Mar 2010

At a glance

  • Drugs Doxorubicin liposomal (Primary) ; Gemcitabine (Primary) ; Vinorelbine (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 03 Mar 2010 Additional trial identifier (P30CA043703) and inclusion/exclusion criteria identified as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Actual end date (Feb 2005) added as reported by ClinicalTrials.gov.
    • 02 Mar 2010 Actual patient number (10) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top